BRIEF published on 12/20/2024 at 07:55, 1 year 2 months ago Le groupe Adler obtient 1,2 milliard d'euros pour le refinancement d'une facilité de crédit de 1 L Refinancement Taux D'intérêt Groupe Adler Conditions Du Marché Installation 1L
BRIEF published on 12/20/2024 at 07:35, 1 year 2 months ago Résultats de l'Assemblée Générale de METAVISIO Actionnaires Assemblée Générale Conseil D'administration Résultats Des Votes Émission D'ORA
BRIEF published on 12/20/2024 at 07:35, 1 year 2 months ago Results of the METAVISIO General Assembly Board Of Directors Shareholders Voting Results General Assembly Issue Of ORA
BRIEF published on 12/20/2024 at 07:20, 1 year 2 months ago Cicor Reports Increased Profitability and Market Share Gains Financial Results Acquisitions Profitability Market Share Strategy 2028
BRIEF published on 12/20/2024 at 07:20, 1 year 2 months ago Cicor annonce une augmentation de sa rentabilité et des gains de parts de marché Résultats Financiers Rentabilité Acquisitions Part De Marché Stratégie 2028
BRIEF published on 12/20/2024 at 07:05, 1 year 2 months ago EU Commission Approval Pending for Arbonia's Climate Division Sale EU Commission Arbonia Shareholder Distribution Merger Approval Midea Group
BRIEF published on 12/20/2024 at 07:05, 1 year 2 months ago La Commission européenne attend l'approbation de la vente de la division climatique d'Arbonia Arbonia Approbation De La Fusion Groupe Midéa Commission Européenne Répartition Des Actionnaires
BRIEF published on 12/20/2024 at 07:05, 1 year 2 months ago HORNBACH Reports Stable Nine-Month Financial Results Gross Margin Sales Growth Market Share Earnings Outlook 9-Month Results
BRIEF published on 12/20/2024 at 07:05, 1 year 2 months ago HORNBACH annonce des résultats financiers stables pour les neuf premiers mois Croissance Des Ventes Marge Brute Part De Marché Perspectives De Bénéfices Résultats Sur 9 Mois
BRIEF published on 12/20/2024 at 07:05, 1 year 2 months ago Innate Pharma à la 43ème J.P. Morgan Healthcare Conference Investisseurs Présentation En Direct Immunothérapie Innate Pharma J.P. Morgan Conference
Published on 03/06/2026 at 00:00, 8 hours 9 minutes ago Redwood AI Exploring Opportunities for its Proprietary AI Platform Across Multiple Industries
Published on 03/05/2026 at 22:55, 9 hours 14 minutes ago Pivotree to Release Fourth Quarter 2025 Financial Results
Published on 03/05/2026 at 20:00, 12 hours 9 minutes ago PPX Hosts Medical Outreach Campaign for Local Communities
Published on 03/05/2026 at 17:55, 14 hours 14 minutes ago ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026
Published on 03/05/2026 at 14:00, 18 hours 9 minutes ago EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/06/2026 at 07:30, 39 minutes ago Mutares signs agreement to sell its portfolio company inTime Group to Tawin Holdings Group
Published on 03/06/2026 at 07:30, 39 minutes ago Steyr Motors publishes 2025 Annual Report – accelerated growth expected in 2026 – new applications in unmanned surface vehicles and power generators as additional growth drivers
Published on 03/06/2026 at 07:30, 39 minutes ago VINCORION plans Initial Public Offering on Frankfurt Stock Exchange
Published on 03/06/2026 at 07:00, 1 hour 9 minutes ago Mikron increases operating profit margin to 10.3%
Published on 03/06/2026 at 07:00, 1 hour 9 minutes ago Press release: Information on Leonteq's shareholder base
Published on 03/05/2026 at 18:40, 13 hours 29 minutes ago 2025 Full-year results FREY: a pan-European platform already creating value
Published on 03/05/2026 at 18:40, 13 hours 29 minutes ago FREY, une plateforme pan-européenne déjà créatrice de valeur
Published on 03/05/2026 at 18:34, 13 hours 35 minutes ago Mersen: Number of shares and voting rights as of February 28, 2026
Published on 03/05/2026 at 18:34, 13 hours 35 minutes ago Mersen : nombre d'actions et de droits de vote au 28 février 2026
Published on 03/05/2026 at 18:32, 13 hours 37 minutes ago LNA SANTE : Répartition de capital et des droits de vote attachés aux actions au 28/02/2026
